1. Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT‐1 study. (1st May 2017) Authors: Marsden, J.R.; Fox, R.; Boota, N.M.; Cook, M.; Wheatley, K.; Billingham, L.J.; Steven, N.M.; Simpkins, D.; Whitham, D.; Chalmers, J.; Bunker, C.; Wharton, S.; Brothwell, S.; Hague, L.; Harwood, C.; Ives, N.; Ramsay, H.; Burrows, L.; Proby, C.; Motley, R. Journal: British journal of dermatology Issue: Volume 176:Number 5(2017) Page Start: 1148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗